Stock research
PLSE Pulse Biosciences, Inc.
Healthcare • Medical - Instruments & Supplies
Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This...…
Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation technology to deliver extremely brief, nanosecond-duration electrical pulses. This advanced method is designed to selectively eliminate target cells without thermal damage, effectively safeguarding adjacent non-cellular tissue. The CellFX System is applied in the treatment of various medical conditions. The company, originally incorporated in 2014 as Electroblate, Inc., officially became Pulse Biosciences, Inc. in December 2015. Its corporate headquarters are situated in Hayward, California.
5Y change
+63.70%
Range high
$35.47
Congress · 90d
0
Insiders · 90d
0
Public signal layer
Who is disclosing activity in PLSE?
Price
Showing 5Y history. Source: FMP historical price full.
- Prev Close
- $35.04
- Day High
- $35.72
- Day Low
- $33.52
- 52w High
- $36.79
- 52w Low
- $12.56
- Volume
- 277,943
- Avg Volume
- Beta
- 1.647
* TTM/most recent where available
Company
- Ticker
- PLSE
- Exchange
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Country
- US
- CEO
- Paul Arthur LaViolette
- Employees
- 116
- Website
- www.pulsebiosciences.com
Key Metrics
- Market Cap
- 2.43B
- P/E
- P/B
- P/S
- EV/EBITDA
- ROE
- Net Margin
- Div Yield
- FCF/Share
* TTM/most recent where available
DCF Valuation
Standard DCF
Levered DCF
Market Price
DCF vs Price (30D window)
Price uses last 30 days; DCF line holds latest value across the window.DCF line = solid green (latest value repeated across window), Price = dashed blue (daily closes).